XERIS PHARMACEUTICALS INC's ticker is XERS and the CUSIP is 98422L107. A total of 87 filers reported holding XERIS PHARMACEUTICALS INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2020 | $1,038,000 | +122.7% | 175,000 | 0.0% | 0.02% | +53.8% |
Q2 2020 | $466,000 | +36.7% | 175,000 | 0.0% | 0.01% | -7.1% |
Q1 2020 | $341,000 | -3.4% | 175,000 | +250.0% | 0.01% | +16.7% |
Q4 2019 | $353,000 | -28.3% | 50,000 | 0.0% | 0.01% | -40.0% |
Q3 2019 | $492,000 | -57.0% | 50,000 | -50.0% | 0.02% | -25.9% |
Q2 2019 | $1,144,000 | +13.9% | 100,000 | 0.0% | 0.03% | -12.9% |
Q1 2019 | $1,004,000 | – | 100,000 | – | 0.03% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Sessa Capital IM, L.P. | 4,172,459 | $20,528,000 | 1.31% |
DELTEC ASSET MANAGEMENT LLC | 693,870 | $3,414,000 | 0.52% |
Alpine Global Management, LLC | 350,000 | $1,722,000 | 0.35% |
Redmile Group, LLC | 2,397,441 | $11,795,000 | 0.14% |
Kamunting Street Capital Management, L.P. | 43,833 | $216,000 | 0.11% |
IHT Wealth Management, LLC | 250,798 | $1,234,000 | 0.10% |
SEARLE & CO. | 34,000 | $167,000 | 0.08% |
GPS Wealth Strategies Group, LLC | 46,025 | $226,000 | 0.08% |
ArrowMark Colorado Holdings LLC | 1,981,909 | $9,751,000 | 0.08% |
Gladstone Institutional Advisory LLC | 51,500 | $253 | 0.05% |